Financials

News Discussions Technicals Seasonals

PMED fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

Peptonic Medical AB engages in the development of oxytocin based products for the treatment of menopausal symptoms. It develops Vagitocin, which focuses on the treatment of vaginal atrophy. The company was founded by Kerstin Uvnas Moberg and Ronald Eric Long on December 2, 2008 and is headquartered in Bromma, Sweden.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends

PMED has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company